ATE312100T1 - Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten - Google Patents

Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten

Info

Publication number
ATE312100T1
ATE312100T1 AT00962889T AT00962889T ATE312100T1 AT E312100 T1 ATE312100 T1 AT E312100T1 AT 00962889 T AT00962889 T AT 00962889T AT 00962889 T AT00962889 T AT 00962889T AT E312100 T1 ATE312100 T1 AT E312100T1
Authority
AT
Austria
Prior art keywords
optionally substituted
chain
substituted
denotes
represented
Prior art date
Application number
AT00962889T
Other languages
English (en)
Inventor
Toshimi Okada
Nobuyuki Kurusu
Keigo Tanaka
Kazuki Miyazaki
Daisuke Shinmyo
Hiroyuki Sugumi
Hironori Ikuta
Hironobu Hiyoshi
Takao Saeki
Mamoru Yanagimachi
Masashi Ito
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE312100T1 publication Critical patent/ATE312100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00962889T 1999-09-28 2000-09-27 Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten ATE312100T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27390599 1999-09-28
JP2000179352 2000-06-15
PCT/JP2000/006665 WO2001023383A1 (en) 1999-09-28 2000-09-27 Quinuclidine compounds and drugs containing the same as the active ingredient

Publications (1)

Publication Number Publication Date
ATE312100T1 true ATE312100T1 (de) 2005-12-15

Family

ID=26550809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00962889T ATE312100T1 (de) 1999-09-28 2000-09-27 Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten

Country Status (20)

Country Link
US (1) US6599917B1 (de)
EP (1) EP1217001B1 (de)
JP (1) JP4206212B2 (de)
KR (1) KR100694687B1 (de)
CN (1) CN100334085C (de)
AT (1) ATE312100T1 (de)
AU (1) AU782114B2 (de)
BR (1) BR0014331A (de)
CA (1) CA2385995C (de)
DE (1) DE60024651T2 (de)
DK (1) DK1217001T3 (de)
ES (1) ES2252063T3 (de)
HU (1) HUP0203514A3 (de)
IL (2) IL148631A0 (de)
MX (1) MXPA02003167A (de)
NO (1) NO328218B1 (de)
NZ (1) NZ517788A (de)
RU (1) RU2266905C2 (de)
TW (1) TWI282794B (de)
WO (1) WO2001023383A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010955D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
ATE366248T1 (de) * 2001-03-27 2007-07-15 Eisai R&D Man Co Ltd N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält
EP1256573A1 (de) 2001-05-09 2002-11-13 Eisai Co., Ltd. Verfahren zur Herstellung eines Stereoisomers von Pyrrolidinderivat
RU2004110717A (ru) * 2001-10-17 2005-10-20 Юсиби, С.А. (Be) Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
US7361671B2 (en) * 2001-11-15 2008-04-22 The Institute For Pharmaceutical Discovery, Inc. Substituted heteroarylalkanoic acids
DE10225537A1 (de) * 2002-06-10 2003-12-18 Bayer Ag N-alkylierte Thiazoliumsalze und Verfahren zu deren Herstellung
GB0218876D0 (en) * 2002-08-13 2002-09-25 Merck Sharp & Dohme Therapeutic agents
CA2499128C (en) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE10334724A1 (de) * 2003-07-30 2005-02-24 Bayer Healthcare Ag N-Biarylamide
WO2005046683A1 (en) * 2003-10-07 2005-05-26 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2005092890A2 (en) 2004-03-25 2005-10-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
CA2679198C (en) 2007-02-26 2011-07-12 Pfizer Products Inc. Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US8420661B2 (en) * 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
US20130071415A1 (en) 2010-05-28 2013-03-21 Biocryst Pharmaceuticals, Inc. Heterocyclic Compounds as Janus Kinase Inhibitors
PL2797416T3 (pl) 2011-12-28 2017-12-29 Global Blood Therapeutics, Inc. Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
US20150284380A1 (en) 2012-10-31 2015-10-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
JP6426694B2 (ja) 2013-03-15 2018-11-21 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP2968299B1 (de) 2013-03-15 2021-01-20 Global Blood Therapeutics, Inc. Verbindungen und verwendungen davon zur modulation von hämoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
AP2016009261A0 (en) 2014-02-07 2016-06-30 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
AU2016273751B2 (en) 2015-06-03 2020-04-02 F. Hoffmann-La Roche Ag Ethynyl derivatives
PL3383392T3 (pl) 2015-12-04 2025-11-17 Global Blood Therapeutics, Inc. Schematy dawkowania dla 2-hydroksy-6-((2-(1-izopropylo-1H-pirazol-5-ilo)pirydyn3-ylo)metoksy)benzaldehydu
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
JP7337174B2 (ja) 2018-09-18 2023-09-01 ニカング セラピューティクス, インコーポレイテッド Srcホモロジー-2ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体
EP3860975B1 (de) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulatoren von hämoglobin zur behandlung von sichelzellenanämie

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015579A1 (en) * 1991-03-08 1992-09-17 Rhone-Poulenc Rorer International (Holdings) Inc. Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors
US5135935A (en) * 1991-05-17 1992-08-04 Merck & Co., Inc. Squalene synthetase inhibitors
GB9127279D0 (en) 1991-12-23 1992-02-19 Ici Plc Heterocyclic derivatives
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−3−カルボン酸誘導体
GB9207961D0 (en) 1992-04-10 1992-05-27 Ici Plc Heterocyclic derivatives
GB9218334D0 (en) 1992-08-28 1992-10-14 Ici Plc Heterocyclic compounds
WO1995031458A1 (en) * 1992-10-13 1995-11-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. 3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
IL109451A0 (en) 1993-04-29 1994-07-31 Zeneca Ltd Heterocyclic derivatives
GB9412145D0 (en) 1994-06-17 1994-08-10 Zeneca Ltd Heterocycles
JPH08134067A (ja) 1994-11-11 1996-05-28 Yamanouchi Pharmaceut Co Ltd キヌクリジン誘導体
JPH08269056A (ja) 1995-03-29 1996-10-15 Chugai Pharmaceut Co Ltd スクアレンシンセターゼ阻害作用を有するキヌクリジン誘導体
US5712270A (en) * 1995-11-06 1998-01-27 American Home Products Corporation 2-arylamidothiazole derivatives with CNS activity
CA2254769A1 (en) 1996-05-20 1997-11-27 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
CN100334085C (zh) 2007-08-29
HUP0203514A2 (hu) 2003-03-28
TWI282794B (en) 2007-06-21
EP1217001B1 (de) 2005-12-07
IL148631A0 (en) 2002-09-12
DE60024651T2 (de) 2006-09-28
CA2385995C (en) 2009-06-16
EP1217001A1 (de) 2002-06-26
AU7446400A (en) 2001-04-30
KR100694687B1 (ko) 2007-03-13
ES2252063T3 (es) 2006-05-16
DE60024651D1 (de) 2006-01-12
NO20021528D0 (no) 2002-03-26
WO2001023383A1 (en) 2001-04-05
KR20020034197A (ko) 2002-05-08
JP4206212B2 (ja) 2009-01-07
BR0014331A (pt) 2003-06-10
NO328218B1 (no) 2010-01-11
US6599917B1 (en) 2003-07-29
RU2266905C2 (ru) 2005-12-27
CN1377349A (zh) 2002-10-30
EP1217001A4 (de) 2002-12-18
IL148631A (en) 2010-04-29
DK1217001T3 (da) 2006-03-20
HUP0203514A3 (en) 2004-01-28
NZ517788A (en) 2003-11-28
MXPA02003167A (es) 2003-10-06
CA2385995A1 (en) 2001-04-05
AU782114B2 (en) 2005-07-07
NO20021528L (no) 2002-05-28

Similar Documents

Publication Publication Date Title
DE60024651D1 (de) Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
DE60119894D1 (de) Piperidinverbindungen und diese enthaltenden medikamente
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
ES2166359T3 (es) Derivado de depsipeptido, su produccion y uso.
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
EP0976748A4 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
AU8799201A (en) Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
ATE279411T1 (de) Fluorszierende marker
DE60223904D1 (de) Benzylaminanalogen
EA200600570A1 (ru) Замещенные 2-карбониламино-6-пиперидинаминопиридины и замещенные 1-карбониламино-3-пиперидинаминобензолы как агонисты 5-ht
NO982873L (no) 1-metylkarbapenemderivater
ATE366248T1 (de) N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält
ES2129123T3 (es) Nuevo derivado de bisoxadiazolidina.
EA200100967A1 (ru) Новое иммунодепрессивное средство
EP1000620A4 (de) Lp(a)MINDERE MITTEL UND INHIBITOREN DER APOPROTEIN (a) PRODUKTION
EP1197211A4 (de) Wirkstoffe zur vorbeugung und behandlung von krebs
EA200001157A2 (ru) Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
DE602005027246D1 (de) Mittel zur linderung von niereninsuffizienz
DE69622393D1 (de) Neue verwendung von pyrazolopyridinverbindungen
DE602004008338D1 (de) Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1217001

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee